Elos Medtech AB Series B | Income Statement
Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
479,448.00
380,856.00
503,661.00
551,989.00
577,915.00
644,711
Cost of Goods Sold (COGS) incl. D&A
328,449.00
278,273.00
376,387.00
406,387.00
425,852.00
479,197
Gross Income
150,999.00
102,583.00
127,274.00
145,602.00
152,063.00
165,514
SG&A Expense
104,166.00
70,023.00
91,205.00
105,010.00
109,327.00
127,188
EBIT
45,985.00
32,547.00
36,027.00
40,592.00
42,736.00
38,326
Unusual Expense
-
-
7,100.00
-
267.00
-
Non Operating Income/Expense
2,446.00
3,846.00
1,178.00
7,514.00
6,438.00
1,105
Interest Expense
7,156.00
5,667.00
7,983.00
10,364.00
10,286.00
11,040
Pretax Income
41,635.00
31,808.00
22,528.00
37,927.00
26,405.00
28,477
Income Tax
8,999.00
8,431.00
6,439.00
11,493.00
3,800.00
7,540
Consolidated Net Income
32,636.00
23,377.00
16,089.00
26,434.00
22,605.00
20,937
Net Income
32,636.00
23,377.00
16,089.00
26,434.00
22,605.00
20,937
Net Income After Extraordinaries
32,636.00
70,015.00
16,089.00
26,434.00
22,605.00
20,937
Net Income Available to Common
32,636.00
28,563.00
16,089.00
26,434.00
22,605.00
20,937
EPS (Basic)
4.90
17.55
2.42
3.97
3.40
2.76
Basic Shares Outstanding
6,654.50
6,654.50
6,654.50
6,654.50
6,654.50
7,598
EPS (Diluted)
4.80
17.55
2.42
3.97
3.40
2.76
Diluted Shares Outstanding
6,796.80
6,654.50
6,654.50
6,654.50
6,654.50
7,598
EBITDA
86,547.00
67,267.00
84,800.00
95,223.00
94,026.00
93,745
Other Operating Expense
848.00
13.00
42.00
-
-
-
Non-Operating Interest Income
360.00
1,082.00
406.00
185.00
126.00
86
About Elos Medtech AB
View Profile
